CAMBRIDGE, U.K., Aug. 31, 2005 (PRIMEZONE) --Astex:
- Astex and Boehringer Ingelheim form a further strategic alliance
-- The alliance will focus on discovery, development and
commercialisation of novel drug candidates
-- Boehringer Ingelheim will pay Astex an upfront fee, fund
research, provide milestone payments and royalties on commercial
sales
-- Astex has drug discovery collaborations with Astellas Pharma,
AstraZeneca, Berlex, Boehringer Ingelheim, Mitsubishi Pharma,
Sanofi-Aventis and Schering AG.
To view this release as a .pdf visit the following link: http://hugin.info/132636/R/1009066/156147.doc